Home/Soleno Therapeutics/Neil M. Cowen, PhD, MBA

NM

Neil M. Cowen, PhD, MBA

Senior Vice President, New Product Planning

Soleno Therapeutics

Therapeutic Areas

Rare Genetic Disorders Genetic Obesity Disorders Prader-Willi Syndrome

Soleno Therapeutics Pipeline

Drug	Indication	Phase
VYKAT XR (setmelanotide)	Hyperphagia in Prader-Willi Syndrome	Marketed
Setmelanotide	Bardet-Biedl Syndrome / Alström Syndrome	Phase 3

Leadership Team at Soleno Therapeutics

Anish Bhatnagar, MD

Chairman of the Board and Chief Executive Officer

Lauren Budesheim

Senior Vice President, People

Dawn Carter Bir

View full Soleno Therapeutics profile